On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...